LifePoint Health (NASDAQ:LPNT) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Thursday.
LPNT has been the subject of several other reports. Mizuho set a $65.00 target price on LifePoint Health and gave the company a “hold” rating in a research note on Monday, July 23rd. Robert W. Baird lowered LifePoint Health from an “outperform” rating to a “neutral” rating and set a $74.00 target price for the company. in a research note on Tuesday, July 24th. Credit Suisse Group upped their target price on LifePoint Health from $58.00 to $65.00 and gave the company a “neutral” rating in a research note on Tuesday, July 24th. Zacks Investment Research lowered LifePoint Health from a “hold” rating to a “sell” rating in a research note on Tuesday, July 24th. Finally, Raymond James lowered LifePoint Health from an “outperform” rating to a “market perform” rating in a research note on Monday, July 23rd. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and one has issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $59.54.
Shares of NASDAQ LPNT traded down $0.07 during trading on Thursday, reaching $64.88. The company had a trading volume of 757,233 shares, compared to its average volume of 507,121. LifePoint Health has a twelve month low of $41.45 and a twelve month high of $65.35. The stock has a market cap of $2.52 billion, a price-to-earnings ratio of 17.87, a price-to-earnings-growth ratio of 1.74 and a beta of 0.51. The company has a quick ratio of 1.63, a current ratio of 1.85 and a debt-to-equity ratio of 1.22.
Hedge funds have recently bought and sold shares of the business. Acadian Asset Management LLC purchased a new stake in LifePoint Health during the second quarter valued at about $263,000. Seven Eight Capital LP purchased a new stake in LifePoint Health during the third quarter valued at about $2,776,000. Spark Investment Management LLC purchased a new stake in LifePoint Health during the second quarter valued at about $1,015,000. MetLife Investment Advisors LLC grew its position in LifePoint Health by 67.9% during the second quarter. MetLife Investment Advisors LLC now owns 40,838 shares of the company’s stock valued at $1,993,000 after acquiring an additional 16,514 shares during the period. Finally, Cubist Systematic Strategies LLC grew its position in LifePoint Health by 116.6% during the second quarter. Cubist Systematic Strategies LLC now owns 33,099 shares of the company’s stock valued at $1,615,000 after acquiring an additional 17,817 shares during the period.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Read More: Moving Average (MA)
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.